The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
Titel:
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis
Auteur:
Pantalone, Kevin M. Kattan, Michael W. Yu, Changhong Wells, Brian J. Arrigain, Susana Jain, Anil Atreja, Ashish Zimmerman, Robert S.